"Nucleoside Deaminases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Catalyze the hydrolysis of nucleosides with the elimination of ammonia.
| Descriptor ID |
D009700
|
| MeSH Number(s) |
D08.811.277.151.486
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nucleoside Deaminases".
Below are MeSH descriptors whose meaning is more specific than "Nucleoside Deaminases".
This graph shows the total number of publications written about "Nucleoside Deaminases" by people in this website by year, and whether "Nucleoside Deaminases" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Nucleoside Deaminases" by people in Profiles.
-
[Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes]. Zhonghua Gan Zang Bing Za Zhi. 2001 Oct; 9(5):300-2.
-
Sensitization of prostate cancer cell lines to 5-fluorocytosine induced by adenoviral vector carrying a CD transcription unit. Chin Med J (Engl). 2001 Sep; 114(9):972-5.
-
Gene therapy for murine liver cancer by adenovirus-mediated cytosine deaminase gene. Zhonghua Gan Zang Bing Za Zhi. 2000 Oct; 8(5):282-4.
-
Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation. Blood. 1998 Jul 15; 92(2):672-82.
-
Induction of adenosine deaminase and 5' nucleotidase activity in cultured human blood monocytes and monocytic leukemia (THP-1) cells by differentiating agents. J Leukoc Biol. 1988 Sep; 44(3):205-11.
-
Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues. Ann N Y Acad Sci. 1985; 451:150-9.
-
Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia. Adv Exp Med Biol. 1984; 165 Pt B:345-50.
-
Effect of 2'-deoxycoformycin on the inhibition of deoxyribonucleic acid synthesis by 9-beta-D-arabinofuranosyladenine 5'-triphosphate. Biochem Pharmacol. 1982 Jun 01; 31(11):2103-9.
-
Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase. Cancer Res. 1979 Sep; 39(9):3655-60.
-
Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo. Biochem Pharmacol. 1979; 28(2):201-6.